Chanchal Choudhary | Developmenal Biology | Best Researcher Award

Ms. Chanchal Choudhary | Developmenal Biology | Best Researcher Award

PhD Scholar, Jawaharlal Nehru University, India 

Chanchal Choudhary is a passionate PhD graduate specializing in molecular and developmental biology. With extensive experience in researching cellular processes, she has contributed to high-impact research on Translationally-Controlled Tumor Proteins (TCTP) and their role in Dictyostelium discoideum. Chanchal has presented her findings at international conferences and co-authored multiple peer-reviewed publications. A recipient of several academic honors, she is dedicated to advancing scientific understanding in the field of developmental biology and molecular mechanisms, aiming to contribute to breakthroughs in health sciences. 🌱🧬

Publication Profile

Orcid

🎓 Education

Ph.D. in Life Sciences (Developmental Biology), Jawaharlal Nehru University, New Delhi (2018-2024)  Research focused on the role of TCTP2 in Dictyostelium discoideum.. M.Sc. in Zoology, Hindu College, University of Delhi (2016–2018) . Specialized in Genomics, Metagenomics, and Epigenetics. B.Sc. (Honors) in Zoology, Acharya Narendra Dev College, University of Delhi (2013–2016)  Graduated with First Division and focused on biological sciences.

💼 Experience

Junior Research Fellow (CSIR), Jawaharlal Nehru University, New Delhi (2018–2020) . Senior Research Fellow (CSIR), Jawaharlal Nehru University, New Delhi (2020–2023) . Dissertation, University of Delhi (2018) on mitochondrial dysfunction in ALS. Innovation Project, Acharya Narendra Dev College (2015–2016), on microbial biodegradation.

🏆 Awards & Honors

CSIR-UGC Junior Research Fellowship (NET), December 2017. Project Assistance Fellowship, University of Delhi (2015–2016). 20th National Children’s Science Congress Presentation, Banaras Hindu University (2012). State-Level Science Model Presentation, 2010

🔬 Research Focus

Chanchal’s research delves into developmental biology, focusing on Translationally-Controlled Tumor Proteins (TCTP) in Dictyostelium discoideum, studying their involvement in cell growth, development, and autophagy regulation. Her work aims to advance understanding of cellular processes and their implications in cancer therapy. 🧬💡

Conclusion

Chanchal Choudhary exhibits the qualities of a highly capable and dedicated researcher. Her technical skills, significant contributions to understanding TCTP2’s role in cell biology, and active engagement in academic forums position her as a leading figure in her field. By enhancing the clinical relevance of her research and expanding her collaborative networks, she will undoubtedly continue to make groundbreaking contributions to developmental biology. Chanchal is highly deserving of the Best Researcher Award, as her work shows immense promise for furthering scientific knowledge and advancing innovations in health and medicine.

Publication Top Notes

  • Choudhary, C., & Saran, S. (2024). In silico analysis of translationally-controlled tumor proteins of social amoeba Dictyostelium discoideum. Biospectra, 19(1), 25–32. ISSN: 0973-7057. DOI: 10.5281/zenodo.14062730.

 

  • Choudhary, C., Jain, B., & Saran, S. (2024). Analyzing the functions of translationally controlled tumor protein 2 during growth, development, and autophagy of Dictyostelium discoideum. Experimental Cell Research. DOI: 10.1016/j.yexcr.2024.114400.

 

Julien Olivet | Epigenetics | Young Scientist Award

Dr.Julien Olivet | Epigenetics | Young Scientist Award

Dr Julien Olivet Rega Institute/KU Leuven Belgium

Julien Olivet is an exceptional candidate for the Young Scientist Award due to his innovative research in structural and chemical biology, leadership in managing research projects, and significant international recognition. His technical expertise, particularly in cryo-EM and drug discovery, stands out. Additionally, his commitment to teaching and science outreach is commendable. To strengthen his candidacy, he could emphasize the real-world impact of his research and diversify his research topics and publications. Overall, Julien’s achievements and contributions make him a highly deserving nominee for the award.

Publication profile

scholar

🎓 Education

PhD in Biochemistry, Molecular and Cellular Biology, Bioinformatics and ModelingUniversité de Liège, Belgium (2015-2021)Thesis: Selective disruption of histone deacetylase complexes by small-molecule inhibitors.MSc in Chemistry of Life and NanomaterialsUniversité de Namur, Belgium (2013-2015)Thesis: Synthesis of alginate/SiO2-TiO2 hybrid material for cell encapsulation.BSc in ChemistryFacultés Universitaires Notre-Dame de la Paix, Namur, Belgium (2009-2013).High School Diploma in Mathematics, Sciences Institut Notre-Dame de Loverval, Belgium (2003-2009).

🔬 Research Experience

Postdoctoral Fellow, KU Leuven (09/2021-present),Focus: Cryo-EM structures of SIN3 histone deacetylase (HDAC) complexes, managing collaborations, drug design.Visiting Senior Scientist, Université de Liège (09/2021-present)Focus: Inhibitors of SIN3 protein in HDAC complexes, drug screening, spin-off development.PhD Research Fellow, Université de Liège (01/2021-06/2021)Focus: Small molecule screening pipelines, virus-host interactions.Visiting FRS-FNRS/WBI PhD Research Fellow, Harvard Medical School (11/2015-12/2020)
Focus: Chemical genetic selections, protein interaction assays.

🏆 Honours and Awards

NSFC-FWO Collaboration Project Award (2024-2025),Research Foundation Flanders (FWO), Belgium.McKinsey & Company Scientific Award (2022)EUR 5000.Marie Skłodowska-Curie Actions (MSCA) European Postdoctoral Fellowship (2022-2024),EUR 191760.Best Oral Presentation Award (2019)Dana-Farber Cancer Institute, USA.

Publication

  • Maximizing binary interactome mapping with a minimal number of assays
    • Authors: SG Choi, J Olivet, P Cassonnet, PO Vidalain, K Luck, L Lambourne, …
    • Year: 2019
  • The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
    • Authors: C Vandermeulen, T O’Grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, …
    • Year: 2021
  • Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells
    • Authors: D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, …
    • Year: 2021
  • A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
    • Authors: J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, …
    • Year: 2022
  • AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
    • Authors: P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, …
    • Year: 2024
  • Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction
    • Authors: SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, …
    • Year: 2023
  • A quantitative mapping approach to identify direct interactions within complexomes
    • Authors: P Trepte, C Secker, SG Choi, J Olivet, ES Ramos, P Cassonnet, S Golusik, …
    • Year: 2021
  • Expanding the HDAC druggable landscape beyond enzymatic activity
    • Authors: J Olivet, SG Choi, S Sierra, TM O’Grady, M de la Fuente Revenga, F Laval, …
    • Year: 2023
  • Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein
    • Authors: SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, …
    • Year: 2021
  • The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
    • Authors: C Vandermeulen, T O’Grady, B Galvan, M Cherkaoui, A Desbuleux, …
    • Year: 2021
  • Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule
    • Authors: SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, …
    • Year: 2021
  • Selective disruption of histone deacetylase complexes by small-molecule inhibitors of protein interactions
    • Author: J Olivet
    • Year: 2021

 

🏅 Conclusion

Julien Olivet is a strong candidate for the Young Scientist Award due to his outstanding research achievements, leadership skills, and contributions to the scientific community. His innovative work in cryo-EM and drug discovery, combined with his active role in mentoring and outreach, aligns well with the criteria for the award. Addressing the areas for improvement, particularly in demonstrating the broader impact of his research and expanding his publication portfolio, could further solidify his candidacy.